Literature DB >> 12244479

Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.

Milos Hricovíni1, Marco Guerrini, Antonella Bisio, Giangiacomo Torri, Annamaria Naggi, Benito Casu.   

Abstract

Binding to proteins usually induces perturbation of nuclear magnetic resonances of ligand molecules. Using sensitive nuclear magnetic resonance (NMR) spectroscopy techniques, these perturbations have been measured for heparin oligosaccharides in aqueous solution in the presence of proteins and the NMR data have been used to characterize the three-dimensional (3D) structure of the oligosaccharides in the bound state. The pentasaccharide corresponding to the active site of heparin/heparan sulfate for antithrombin (AT) adopts in the complex with the protein a conformation different from that in the absence of the protein. A notable difference involves the 2-O-sulfated iduronic acid (IdoA2S) residue, which is driven to adopt an exclusively skew-boat @affil2: 2S 0 form in the complex. In addition, complexing induces a change in the geometry around the glycosidic linkage between the nonreducing end glucosamine and the adjacent glucuronic acid residue as compared with the free state. NMR and molecular modeling data also indicate that the 2-O-sulfate group in the IdoA2S residue is not directly involved in binding to AT. This suggests that its role is mainly that of affecting the conformational equilibrium of this residue, leading to a 3D structure of pentasaccharide in the bound state that meets the stereochemical requirements of the receptor and results in high-affinity binding to the protein. On the other hand, NMR studies of heparin tetrasaccharides in the presence of fibroblast growth factors FGF-1 and FGF-2 indicate that FGF binding stabilizes the @affil1: 1C 4 conformation of the IdoA2S residue directly involved in binding. These studies also confirm the crucial role of the 6-O-sulfate group on at least one glucosamine residue in the formation of the complex with FGF-1 but not with FGF-2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244479     DOI: 10.1055/s-2002-34301

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  8 in total

Review 1.  Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.

Authors:  Tobias Miller; Melissa C Goude; Todd C McDevitt; Johnna S Temenoff
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

2.  Antithrombin-binding oligosaccharides: structural diversities in a unique function?

Authors:  Marco Guerrini; Pierre A J Mourier; Giangiacomo Torri; Christian Viskov
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

Review 3.  Applications of isotopes in advancing structural and functional heparanomics.

Authors:  Vy M Tran; Thao K N Nguyen; Karthik Raman; Balagurunathan Kuberan
Journal:  Anal Bioanal Chem       Date:  2010-09-14       Impact factor: 4.142

4.  Spatially localized recruitment of anti-inflammatory monocytes by SDF-1α-releasing hydrogels enhances microvascular network remodeling.

Authors:  J R Krieger; M E Ogle; J McFaline-Figueroa; C E Segar; J S Temenoff; E A Botchwey
Journal:  Biomaterials       Date:  2015-10-23       Impact factor: 12.479

5.  Preparation and characterization of (15)N-enriched, size-defined heparan sulfate precursor oligosaccharides.

Authors:  Crystal Sigulinsky; Ponnusamy Babu; Xylophone V Victor; Balagurunathan Kuberan
Journal:  Carbohydr Res       Date:  2009-11-03       Impact factor: 2.104

Review 6.  Tools for the Quality Control of Pharmaceutical Heparin.

Authors:  Anthony Devlin; Courtney Mycroft-West; Patricia Procter; Lynsay Cooper; Scott Guimond; Marcelo Lima; Edwin Yates; Mark Skidmore
Journal:  Medicina (Kaunas)       Date:  2019-09-25       Impact factor: 2.430

7.  Unusual glycosaminoglycans from a deep sea hydrothermal bacterium improve fibrillar collagen structuring and fibroblast activities in engineered connective tissues.

Authors:  Karim Senni; Farida Gueniche; Sylvie Changotade; Dominique Septier; Corinne Sinquin; Jacqueline Ratiskol; Didier Lutomski; Gaston Godeau; Jean Guezennec; Sylvia Colliec-Jouault
Journal:  Mar Drugs       Date:  2013-04-23       Impact factor: 5.118

8.  Conformational Modulation of Iduronic Acid-Containing Sulfated Glycosaminoglycans by a Polynuclear Platinum Compound and Implications for Development of Antimetastatic Platinum Drugs.

Authors:  Anil K Gorle; Thomas Haselhorst; Samantha J Katner; Arun V Everest-Dass; James D Hampton; Erica J Peterson; Jennifer E Koblinski; Eriko Katsuta; Kazuaki Takabe; Mark von Itzstein; Susan J Berners-Price; Nicholas P Farrell
Journal:  Angew Chem Int Ed Engl       Date:  2020-12-23       Impact factor: 15.336

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.